Get started
Author

Erik J. M. Toonen

Observed names: E J M Toonen, E Toonen, E. Toonen, E.J.M., Toonen, ERIK J.M. TOONEN, Erik J M Toonen, Erik J. M. Toonen (176167), Erik J.M. Toonen, Erik JM Toonen, Erik Jm Toonen, Erik Toonen, Toonen, Erik, Toonen, Erik J. M., Toonen, Erik JM
Observed institutions: Semmelweis University, Radboud University Nijmegen, Copenhagen University Hospital, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Hycult Biotech (Netherlands), National University Hospital, MSD (Netherlands), Hungarian Research Network
ORCID: 0000-0001-9039-635X
Observed ORCID: 0000-0001-9039-635X
OpenAlex ID: A5035174490
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
2021 · Laura Bergamaschi, Federica Mescia, et al. · Immunity · 338
PDF
IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies
2018 · Andreea-Manuela Mirea, Cees J. Tack, et al. · Trends in Molecular Medicine · 144
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
2020 · Matthew S. Buckland, James B. Galloway, et al. · Nature Communications · 118
PDF
Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes
2020 · Aline H de Nooijer, Inge Grondman, et al. · The Journal of Infectious Diseases · 114
PDF
Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor
2010 · Raoul Frijters, Wilco Fleuren, et al. · BMC Genomics · 103
PDF
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis
2012 · Maša Umiċeviċ Mirkov, Jing Cui, et al. · Annals of the Rheumatic Diseases · 99
Tumour necrosis factor α −308G→A polymorphism is not associated with response to TNFα blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis
2009 · Stephan Pavy, Erik J M Toonen, et al. · Annals of the Rheumatic Diseases · 84
Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes
2019 · Andreea-Manuela Mirea, Erik J. M. Toonen, et al. · Molecular Medicine · 77
PDF
Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis
2012 · Erik J. M. Toonen, Christian Gilissen, et al. · PLoS ONE · 68
PDF
Pitfalls in complement analysis: A systematic literature review of assessing complement activation
2022 · Ricardo J. M. G. E. Brandwijk, Marloes A. H. M. Michels, et al. · Frontiers in Immunology · 67
PDF
Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD
2020 · Andreea-Manuela Mirea, Rinke Stienstra, et al. · Inflammation · 67
PDF
Prednisolone-induced beta cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells
2011 · Margot M.L. Linssen, Daniel H. van Raalte, et al. · Cellular Signalling · 66
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
2024 · Kirsten Baillie, Helen E. Davies, et al. · Med · 62
PDF
Pharmacogenetics of Anti-TNF Treatment in Patients with Rheumatoid Arthritis
2007 · Marieke JH Coenen, Erik JM Toonen, et al. · Pharmacogenomics · 50
Gene expression profiling in rheumatoid arthritis: current concepts and future directions
2008 · E J M Toonen, P Barrera, et al. · Annals of the Rheumatic Diseases · 49
A Family Affair: Addressing the Challenges of Factor H and the Related Proteins
2021 · Felix Poppelaars, Elena Goicoechea de Jorge, et al. · Frontiers in Immunology · 45
PDF
Oxidative Stress Increases Endogenous Complement-Dependent Inflammatory and Angiogenic Responses in Retinal Pigment Epithelial Cells Independently of Exogenous Complement Sources
2019 · Timon-Orest Trakkides, Nicole Schäfer, et al. · Antioxidants · 45
PDF
Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity
2023 · Aline H. de Nooijer, Antigone Kotsaki, et al. · Critical Care · 43
PDF
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis
2008 · E J M Toonen, M J H Coenen, et al. · Annals of the Rheumatic Diseases · 42
Complement-mediated Damage to the Glycocalyx Plays a Role in Renal Ischemia-reperfusion Injury in Mice
2019 · Anjan K. Bongoni, Bo Lu, et al. · Transplantation Direct · 40
Activation of Proteinase 3 Contributes to Nonalcoholic Fatty Liver Disease and Insulin Resistance
2016 · Erik J M Toonen, Andreea-Manuela Mirea, et al. · Molecular Medicine · 40
PDF
HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis
2008 · Frank A. D. T. G. Wagener, Erik J. M. Toonen, et al. · Arthritis & Rheumatism · 39
Frailty is related to serum inflammageing markers: results from the VITAL study
2023 · Yannick van Sleen, Sudarshan A Shetty, et al. · Immunity & Ageing · 34
PDF
Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs
2022 · Lisa Hurler, Erik J. M. Toonen, et al. · Frontiers in Immunology · 32
PDF
Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome
2010 · Marieke J. H. Coenen, Christian Enevold, et al. · PLoS ONE · 31
PDF
Works count: 97
Citation count: 2,239
H-index: 26
I10-index: 39
Year
Topic
Type